AME · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $7.40B | $6.94B | $6.60B | $6.15B | $5.55B | $4.54B | $5.16B | $4.85B |
| Cost of Revenue | $4.73B | $4.46B | $4.21B | $4.01B | $3.63B | $3.00B | $3.37B | $3.19B |
| Research & Development | $236.10M | $236.60M | $220.80M | $198.80M | $194.20M | $158.90M | $161.90M | $141.00M |
| Selling, General & Administrative | $757.12M | $696.90M | $677.01M | $644.58M | $603.94M | $515.63M | $610.28M | $584.02M |
| Operating Expenses | $5.49B | $5.16B | $4.89B | $4.65B | $4.24B | $3.51B | $3.98B | $3.77B |
| Operating Income | $1.91B | $1.78B | $1.71B | $1.50B | $1.31B | $1.03B | $1.18B | $1.08B |
| Interest Expense | — | — | $81.80M | $83.19M | $80.38M | $86.06M | $88.48M | $82.18M |
| Other Income / (Expense) | -$30.72M | -$5.06M | -$19.25M | $11.19M | -$5.12M | $140.49M | -$19.15M | -$5.62M |
| Income Before Taxes | $1.80B | $1.66B | $1.61B | $1.43B | $1.22B | $1.08B | $1.07B | $987.75M |
| Provision for Income Taxes | $318.20M | $285.42M | $293.22M | $269.15M | $233.12M | $209.87M | $208.45M | $209.81M |
| Net Income | $1.48B | $1.38B | $1.31B | $1.16B | $990.05M | $872.44M | $861.30M | $777.93M |
| Basic EPS | $6.42 | $5.95 | $5.70 | $5.04 | $4.29 | $3.80 | $3.78 | $3.37 |
| Diluted EPS | $6.40 | $5.93 | $5.67 | $5.01 | $4.25 | $3.77 | $3.75 | $3.34 |
| Basic Shares Outstanding | 230.45M | 231.26M | 230.52M | 230.21M | 230.96M | 229.44M | 227.76M | 230.82M |
| Diluted Shares Outstanding | 231.26M | 232.17M | 231.51M | 231.54M | 232.81M | 231.15M | 229.40M | 232.71M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $8.27 | $8.23 | $8.32 | 2 | ↑1 ↓0 |
| Dec 2027 | $8.82 | $8.47 | $9.15 | 11 | ↑2 ↓0 |
| Dec 2028 | $9.38 | $9.10 | $9.94 | 4 | ↑1 ↓0 |
| Dec 2029 | $10.26 | $9.53 | $10.98 | 2 | ↑0 ↓0 |
